A Phase II Study of Dose-Dense Temozolomide and Lapatinib for Recurrent Low- Grade and Anaplastic Ependymoma
[Protocol 09-031] |
Omuro, Antonio |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
A Phase I Study of Hypofractionated Stereotactic Radiosurgery with Bevacizumab to Treat Recurrent Malignant Glioma
[Protocol 11-057] |
Omuro, Antonio |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
A Phase I Study of Carboxyamidotriazole Orotate Plus Temozolomide in Patients with Glioblastoma Multiforme and Other Recurrent Malignant Gliomas
[Protocol 12-007] |
Omuro, Antonio |
|
A Phase II Study of Combination Chemotherapy with and without Low-Dose Whole-Brain Radiation for Primary Central Nervous System Lymphoma
[Protocol 11-125] |
Omuro, Antonio |
- Lymphoma
- Pediatric Brain Tumors
|
Glioma International Case-Control Study
[Protocol 10-073] |
Olson, Sara |
- Brain Tumors, Primary
- Pediatric Brain Tumors
|
Melanoma Survivors: Health Behaviors, Surveillance, Psychosocial Factors, and Family Concerns
[Protocol 06-128] |
Oliveria, Susan |
|
Clinical Significance of Germline BRCA Mutations
[Protocol 96-051] |
Offit, Kenneth |
- Breast Cancer
- Colorectal Cancer
- Hereditary Cancer & Genetics
- Ovarian Cancer
- Prostate Cancer
|
Collection of Saliva Samples for Genetic Epidemiology Studies of Cancer and Aging
[Protocol 06-102] |
Offit, Kenneth |
- Geriatrics
- Hereditary Cancer & Genetics
|
Ascertainment of Families for Genetic Studies of Familial Lymphoproliferative Disorders
[Protocol 00-069] |
Offit, Kenneth |
- Hereditary Cancer & Genetics
- Leukemia
- Lymphoma
- Hodgkin's Disease
- Non-Hodgkin's Lymphoma
|
Analysis of Blood and Salivary Samples for Genetic Studies of Familial Cancers
[Protocol 93-102] |
Offit, Kenneth |
- Hereditary Cancer & Genetics
|
EMPOWER Study: Promoting Breast Cancer Screening in Women Who Survived Childhood Cancer
[Protocol 10-104] |
Oeffinger, Kevin |
- Breast Cancer
- Survivorship
|
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055] |
O'Reilly, Richard |
|
A Phase II Study Evaluating the Use of Donated EBV-Immune T Cells to Treat Transplant Recipients with EBV
[Protocol 11-130] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Lymphoma
|
A Phase I/II Study of the Toxic and Therapeutic Effects of T Cells in the Treatment of Epstein Barr Virus-Associated Lymphoproliferative Disorders
[Protocol 95-024] |
O'Reilly, Richard |
- Blood & Marrow Stem Cell Transplantation
- Blood and Marrow Transplantation
- Leukemia
- Lymphoma
|
A Phase II Study of CMV-Immune T cells for the Treatment of Cytomegalovirus Infection after Stem Cell Transplantation
[Protocol 12-086] |
O'Reilly, Richard |
- Blood & Marrow Stem Cell Transplantation
|
A Prospective Natural History Study of the Diagnosis, Treatment, and Outcomes of Children with SCID Disorders
[Protocol 10-150] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Hematology
|
Biparental HLA Haplotype Disparate T-cell Depleted Transplants for Patients Lacking an HLA-Compatible Donor
[Protocol 12-053] |
O'Reilly, Richard |
- Blood & Marrow Stem Cell Transplantation
- Hematology
- Hematologic Disorders
- Myelodysplastic Syndrome
- Leukemia
- Acute Lymphoblastic Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Lymphoma
|
A Phase II Trial of Transplants from HLA-Compatible Donors with T-cell Depleted Peripheral Blood Stem Cells Isolated by the CliniMACS System for the Treatment of Patients with Hematologic Malignancies and Disorders
[Protocol 10-050] |
O'Reilly, Richard |
- Blood and Marrow Transplantation
- Hematology
- Multiple Myeloma
- Myelodysplastic Syndrome
- Leukemia
- Chronic Myelocytic Leukemia
- Myelodysplastic Syndrome
- Lymphoma
|
A Phase IB/II Study of OMP-59R5 with Gemcitabine in Patients with Previously Untreated Metastatic Pancreatic Cancer
[Protocol 12-234] |
O'Reilly, Eileen |
|
Two Phase II Studies of Veliparib for Pancreatic Cancer with a BRCA or PALB2 Mutation: Gemcitabine & Cisplatin with/without Veliparib in Untreated Pancreatic Cancer (Part I) & Veliparib Alone for Patients with Previously Treated Pancreatic Cancer (Part II
[Protocol 12-045] |
O'Reilly, Eileen |
- Hepatobiliary
- Upper Gastrointestinal
|
